Efficacy and safety profile of boceprevir- or telaprevir-based triple therapy or dual peginterferon alfa-2a or alfa-2b plus ribavirin therapy in chronic hepatitis C: the real-world...

por Mangia, Alessandra, Foster, Graham R., Berg, Christoph P., Curescu, Manuela, Ledinghen, Victor De, Habersetzer, François, Manolakopoulos, Spilios, Negri, Elisa, Papatheodoridis, George, Ahlers, Silke, Castillo, Marco, Bakalos, Georgios, Mauss, Stefan
Publicado 2017